Additional file 1: of Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment

Mazen Nasrallah, Yannick Pouliot, Bjoern Hartmann, Patrick Dunn, Elizabeth Thomson, Jeffrey A. Wiser, Atul J. ButteFigshare 2015 · DOI

Abstract

ImmPort-FLOCK Output. Sample FLOCK analysis of an FCS file (903935_SN05_I019.fcs). Distinct populations identified by clustering are color-coded. a Dot plot representations of populations defined by FSC, SSC, CD1c, CD21, CD5, CD19 and CD23. b Summary of each population described by an expression profile of approximate marker intensity (1 = negative, 2 = low, 3 = positive, 4 = high). c Gridding definitions used to identify total lymphocyte, monocyte and granulocyte populations on the basis of FSC and SSC. (PDF 643 kb)
BibTeX
@inproceedings{nasrallah2015additional,
  author = {Mazen Nasrallah and Yannick Pouliot and Bjoern Hartmann and Patrick Dunn and Elizabeth Thomson and Jeffrey A. Wiser and Atul J. Butte},
  title = {{Additional file 1: of Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment}},
  booktitle = {Figshare},
  year = {2015},
  doi = {10.6084/m9.figshare.4446917},
}

Loading related content...

Figure